Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis

Rheumatol Adv Pract. 2018 Jan 30;2(1):rky001. doi: 10.1093/rap/rky001. eCollection 2018.
No abstract available

Publication types

  • Case Reports